Federal Register: FDA Announces Approval of Bixlenvo Tablets Redeeming Priority Review Voucher
October 28, 2026
October 28, 2026
WASHINGTON, Oct. 28 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following action in the Federal Register.
* * *
Notice of Approval of Product Under Voucher: Material Threat Medical Countermeasure (MCM) Priority Review Voucher; Bixlenvo (Bictegravir and Lenacapavir)
The Food and Drug Administration (FDA) is announcing the approval of a product redeeming a material threat MCM priority review voucher. The . . .
* * *
Notice of Approval of Product Under Voucher: Material Threat Medical Countermeasure (MCM) Priority Review Voucher; Bixlenvo (Bictegravir and Lenacapavir)
The Food and Drug Administration (FDA) is announcing the approval of a product redeeming a material threat MCM priority review voucher. The . . .